Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/07/1999 | DE19727978A1 Preparation of medicaments containing sparingly water-soluble metal complexes used to treat cancer |
01/07/1999 | DE19727362A1 Polymerisate aus ungesättigten Saccharidsäuren und deren Derivaten sowie deren Copolymerisate mit ethylenisch ungesättigten Verbindungen und Verfahren zu ihrer Herstellung Polymers of unsaturated Saccharidsäuren and derivatives thereof and copolymers thereof with ethylenically unsaturated compounds and methods for their preparation |
01/07/1999 | DE19727117A1 Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Phenylalkylderivate, pharmaceutical compositions containing them and methods for their preparation |
01/07/1999 | CA2765222A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
01/07/1999 | CA2297723A1 Synthesis of dihydrohonokiol compositions |
01/07/1999 | CA2295747A1 Use of a drug capable of modulating the regulation of upc-2 and method for screening for potential drugs against obesity |
01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
01/07/1999 | CA2295239A1 Sulfonamide compounds and medicinal use thereof |
01/07/1999 | CA2295153A1 Antithrombotic agents |
01/07/1999 | CA2295098A1 Calcium blockers to treat proliferative vitreoretinopathy |
01/07/1999 | CA2295089A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
01/07/1999 | CA2295076A1 New combination of antiasthma medicaments |
01/07/1999 | CA2295028A1 Proliposome powders for inhalation stabilised by tocopherol |
01/07/1999 | CA2294725A1 Intra-oral antioxidant preparations |
01/07/1999 | CA2294550A1 Use of phospholamban inhibitors for increasing coronary flow |
01/07/1999 | CA2294505A1 Benzimidazole derivatives |
01/07/1999 | CA2294343A1 Method for optimizing retinal and optic nerve health |
01/07/1999 | CA2294250A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
01/07/1999 | CA2294240A1 Antithrombotic agents |
01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
01/07/1999 | CA2294126A1 Antithrombotic agents |
01/07/1999 | CA2294042A1 Antithrombotic agents |
01/07/1999 | CA2293565A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
01/07/1999 | CA2292794A1 Ace-inhibitor nitric salts |
01/07/1999 | CA2291734A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
01/07/1999 | CA2291689A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
01/07/1999 | CA2290364A1 Method of producing tiazofurin and other c-nucleosides |
01/07/1999 | CA2288786A1 Radiolabeled farnesyl-protein transferase inhibitors |
01/07/1999 | CA2288744A1 Phenylalkyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
01/07/1999 | CA2241328A1 Use of gamma linolenic acid to prevent oxidative stress |
01/07/1999 | CA2217902A1 Use of gammahydroxybutyrric acid for the treatment of demential syndromes |
01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
01/06/1999 | CN1204367A Antifungal proteins |
01/06/1999 | CN1204366A Antifungal protein |
01/06/1999 | CN1204345A Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
01/06/1999 | CN1204342A Antineoplastic peptides |
01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
01/06/1999 | CN1204337A Production of salt clavulanic acid |
01/06/1999 | CN1204336A Cephalosporin antibiotics |
01/06/1999 | CN1204335A 4a,5a,8a,8b-tetrahydro-6H-pyrrolo [3',4' : 4,5] furo (3,2-b] pyridine-6,8 [7H]-dione derivatives for use in controlling endoparasites and method |
01/06/1999 | CN1204334A Process for preparation of growth hormone secretagogue |
01/06/1999 | CN1204333A Salts of N-(4-oxo-2-(1H-tetrazoyl-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy) benzamide |
01/06/1999 | CN1204332A Method for synthesis of benzimidazole compound |
01/06/1999 | CN1204329A Tax-11-ene-13 'alpha'-Yl (2R,3S)-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate and method for preparing same |
01/06/1999 | CN1204327A Pharmaceutically active quinazoline compounds |
01/06/1999 | CN1204326A Arylethenesulfonamide derivatives and drug composition containing the same |
01/06/1999 | CN1204323A Use of tricyclic 1,4-dihydro-1,4-dioxo-1 H-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
01/06/1999 | CN1204321A Phenanthridine derivatives, method of producing them and medicaments containing phenanthridine derivatives |
01/06/1999 | CN1204320A Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors |
01/06/1999 | CN1204316A O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
01/06/1999 | CN1204314A Process for preparing optically active carboxylic acids |
01/06/1999 | CN1204264A Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and kappa-2 opioid agonist |
01/06/1999 | CN1204261A Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroxy-fatty acid |
01/06/1999 | CN1204260A Percutaneous tulobuterol preparation and process for producing the same |
01/06/1999 | CN1204259A Intimal thickening inhibitor |
01/06/1999 | CN1204258A Novel method |
01/06/1999 | CN1204232A Composition for organ cryopreservation and treatment of viral and bacterial infections |
01/06/1999 | CN1203919A 3'-monophosphorylated oligonucleotides |
01/06/1999 | CN1203918A Mistletoe extract and its use |
01/06/1999 | CN1203917A Zinc pipemidate its synthetic process and zinc pipemidate ointment |
01/06/1999 | CN1203916A Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
01/06/1999 | CN1203790A Medicine for curing and operating purpose and its preparing method |
01/06/1999 | CN1203789A Medicine for therapeutic and operating purpose and preparing method thereof |
01/06/1999 | CN1203788A Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflammatory drug and phenylpropionic acid derivative |
01/06/1999 | CN1203787A Ketoprofen slow-releasing tablet and its preparing method |
01/06/1999 | CN1203786A Nicardipine hydrochloride slow release tablet and its preparing method |
01/06/1999 | CN1041520C Quinoline or quinazoline derivatives, their production and use |
01/06/1999 | CN1041493C Preparing process for amino-acid oral liquid |
01/05/1999 | US5856580 Cleavage of an oxybride |
01/05/1999 | US5856574 Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
01/05/1999 | US5856569 Alkyl alkanoylacetate is reacted with an n-propyl halide in a biphasic system in the presence of a base and a phase transfer catalyst. |
01/05/1999 | US5856566 Colored particles; irradiation of crystals |
01/05/1999 | US5856564 Condensed benzazepine derivative and pharmaceutical composition thereof |
01/05/1999 | US5856537 Inhibitors of oleamide hydrolase |
01/05/1999 | US5856535 Viricides; anticancer agents; antiangiogenic agents |
01/05/1999 | US5856532 Isolating the xyloside analogue of taxols from stem bark of taxus wallichiana, extracting, heating, precipitating, dissolving in a solvent, cleaving diol of xyloside to dialdehyde, reducing, acetylating, protecting, deprotecting |
01/05/1999 | US5856529 Adjustment of nervous system, endocrine function; reproduction, body weight and metabolism |
01/05/1999 | US5856526 Comminution; solvent extraction |
01/05/1999 | US5856517 Substituted pyrroles |
01/05/1999 | US5856515 Electron-deficient porphyrins and processes and intermediates for preparing same |
01/05/1999 | US5856514 Arylpyrazole fungicides |
01/05/1999 | US5856509 Hypotensive agents |
01/05/1999 | US5856506 (oxazolylcarbonylamino)ethylamino glutamate derivatives |
01/05/1999 | US5856503 Anticholesterol agents |
01/05/1999 | US5856490 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
01/05/1999 | US5856489 Catalytic hydrogenation |
01/05/1999 | US5856487 Oral administering |
01/05/1999 | US5856484 Sulfonylaminopyrimidine carboxylic acid derivatives having endothelin inhibiting activity |
01/05/1999 | US5856481 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
01/05/1999 | US5856475 4-thia-1-azabicyclo/3.2.0/Heptane-3-Imino-2-isopropylidene-7-oxo-analogons of beta-lactams, processes for their preparation and the use thereof |
01/05/1999 | US5856463 PSKH-1 ribozymes |
01/05/1999 | US5856462 Oligonucleotides having modified CpG dinucleosides |
01/05/1999 | US5856461 Antibody |
01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
01/05/1999 | US5856363 Arthritis treatment |
01/05/1999 | US5856362 Medicaments for the treatment of toxoplasmosis |
01/05/1999 | US5856361 Capsaicin plus plant extract analgesic |